Management of Secondary Hypogonadism with Suppressed LH
This 30-year-old male has secondary (hypogonadotropic) hypogonadism requiring immediate evaluation for pituitary pathology and fertility-preserving treatment options, not testosterone replacement therapy. 1
Critical Diagnostic Clarification
Your laboratory values appear to contain reporting errors that need immediate verification:
- Testosterone 33.1 mmol/L (if accurate) = approximately 9,540 ng/dL, which is supraphysiologic and inconsistent with hypogonadism 1
- Free testosterone 980 nmol/L (if accurate) = approximately 282,000 ng/dL, which is physiologically impossible 1
- LH <0.1 is profoundly suppressed, indicating either secondary hypogonadism OR exogenous androgen use 1, 2
Most likely scenario: These values suggest either laboratory error in units OR exogenous testosterone/anabolic steroid use causing suppression of the hypothalamic-pituitary-gonadal axis. 2, 3
Immediate Evaluation Required
1. Confirm True Hormone Status
- Repeat morning (8-10 AM) total testosterone using an accurate, reliable assay on at least two separate occasions 1
- Measure LH and FSH simultaneously to confirm hypogonadotropic pattern 1
- Obtain detailed medication/supplement history, specifically asking about testosterone, anabolic steroids, opioids, or GnRH agonists/antagonists 2
2. Rule Out Pituitary Pathology (MANDATORY)
If testosterone is truly low with LH <0.1, this patient requires:
- Serum prolactin measurement - elevated prolactin can indicate prolactinoma 1
- Pituitary MRI - men with testosterone <150 ng/dL and low/low-normal LH require imaging regardless of prolactin levels to identify non-secreting adenomas 1
- If prolactin is elevated, repeat measurement to exclude spurious elevation, then refer to endocrinology 1
- Assess other pituitary hormones (TSH, cortisol, IGF-1) to rule out combined pituitary hormone deficiency 1, 2
3. Evaluate for Secondary Causes
- Iron studies - hemochromatosis can cause hypogonadotropic hypogonadism 1, 4
- HIV testing - HIV infection is associated with hypogonadism 1, 2
- Review for systemic diseases - chronic illness, organ failure can suppress gonadotropins 2, 4
Treatment Algorithm
If Fertility is Desired (Age 30 Makes This Critical)
Testosterone replacement therapy is absolutely contraindicated if fertility is a consideration. 1, 3
- First-line: Gonadotropin therapy (hCG with or without FSH) to stimulate testicular function and preserve spermatogenesis 1, 5
- Alternative: Selective estrogen receptor modulators (SERMs) like clomiphene for men with secondary hypogonadism wishing to preserve fertility 1
- Aromatase inhibitors may also be considered in combination with other therapies 1
If Fertility is NOT Desired
Only after confirming true hypogonadism and completing pituitary evaluation:
- Testosterone replacement therapy improves sexual function, well-being, muscle mass, and bone density 1
- Transdermal preparations (gel/patch) provide stable daily testosterone levels and are generally preferred 1, 3
- Injectable testosterone esters are cost-effective alternatives with less frequent dosing 1, 4
- Monitor testosterone levels at 2-3 months after initiation, then periodically 1, 3
- Target testosterone range: 350-750 ng/dL 3
Critical Pitfalls to Avoid
- Never start testosterone without ruling out pituitary tumor - this can mask serious pathology 1, 4
- Never use testosterone in men desiring fertility - it suppresses spermatogenesis and can cause azoospermia 1, 3
- Never diagnose hypogonadism on single measurement - requires two morning samples 1
- Never ignore exogenous androgen use - anabolic steroids, testosterone, or SARMs will suppress LH and cause secondary hypogonadism 2, 3
Monitoring on Treatment
- Hematocrit - testosterone increases red blood cell production 3
- Prostate examination and PSA - baseline and periodic monitoring 1, 3
- Lipid panel and glucose - testosterone affects metabolic parameters 1
- Bone density - if prolonged hypogonadism was present 1
Referral Indications
Immediate endocrinology referral if: 1
- Persistently elevated prolactin
- Pituitary mass on imaging
- Multiple pituitary hormone deficiencies
- Testosterone <150 ng/dL with low LH (requires MRI first) 1